Floatz logo

Therapeutic Asset Ratings

862 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Epirubicin
Locally Advanced Malignant Solid Neoplasm
Mayo ClinicP2BB (65)
FILGRASTIM
Breast Adenocarcinoma
Mayo ClinicP2BB (65)
FLUTICASONE
Metastatic Cancer
Mayo ClinicP2BB (65)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine
Advanced Fallopian Tube High Grade Serous Adenocarcinoma
Mayo ClinicP2BB (65)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine
Advanced Ovarian Endometrioid Adenocarcinoma
Mayo ClinicP2BB (65)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine
Advanced Primary Peritoneal High Grade Serous Adenocarcinoma
Mayo ClinicP2BB (65)
Multi-Epitope Folate Receptor Alpha-Loaded Dendritic Cell Vaccine
Recurrent Primary Peritoneal Carcinoma
Mayo ClinicP2BB (65)
Nivolumab
Metastatic Pancreatic Cancer
Mayo ClinicP2BB (65)
Pembrolizumab
Locally Advanced Malignant Solid Neoplasm
Mayo ClinicP2BB (65)
Romidepsin
Recurrent Breast Cancer
Mayo ClinicP2BB (65)
PITTSBURGH COMPOUND B UNLABELLED
Alzheimer's Disease
Mayo ClinicP4BB (64)
Epirubicin
Head and Neck Neoplasms
Mayo ClinicP3BB (64)
Histrelin
Prostate Cancer
Mayo ClinicP3BB (64)
Methylene Blue
Hematopoietic and Lymphoid System Neoplasm
Mayo ClinicP3BB (64)
Methylene Blue
Stomatitis
Mayo ClinicP3BB (64)
Pembrolizumab
Head and Neck Neoplasms
Mayo ClinicP3BB (64)
Zofran
Marginal Zone Lymphoma
Mayo ClinicP3BB (64)
Cyclophosphamide
Recurrent Ovarian Carcinosarcoma
Mayo ClinicP2BB (64)
Epirubicin
Cervical Carcinoma
Mayo ClinicP2BB (64)
Nivolumab
Pancreatic Adenocarcinoma
Mayo ClinicP2BB (64)
Pembrolizumab
Cervical Carcinoma
Mayo ClinicP2BB (64)
Sargramostim
Metastatic Cancer
Mayo ClinicP2BB (64)
Sargramostim
Metastatic Melanoma
Mayo ClinicP2BB (64)
TIPIRACIL
Refractory Colorectal Carcinoma
Mayo ClinicP2BB (64)
Trifluridine
Refractory Colorectal Carcinoma
Mayo ClinicP2BB (64)
Showing 101 to 125 of 862 assets
PreviousPage 5 of 35Next